Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Paysign (PAYS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Paysign is rated a Buy at $10 despite losing a major plasma customer, as the selloff is seen as exaggerated. The Pharma segment now drives over half of revenue, growing 110% with higher margins and a larger TAM, offsetting plasma center losses. Management raised guidance for revenue, gross margin, net income, and EBITDA, projecting continued growth and margin expansion into FY26.
Paysign NASDAQ: PAYS reported record third-quarter revenue, operating income and adjusted EBITDA as growth in its patient affordability business more than offset slower growth in plasma payment processing.
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the third quarter 2026. Third Quarter 2026 Financial Highlights Revenues of $30.80 million in Q3'26, up 42.6% from Q3'25 Pharma revenue increased 109.8% to $16.62 million in Q3'26 versus Q3'25; added 62 net patient a.
Favorable post-midterm election momentum, plus annual market seasonality accelerating with Black Friday, could provide powerful tailwinds for equities. Meanwhile, extreme market fear and macroeconomic uncertainty can create attractive buying opportunities in under-the-radar technology companies with strong fundamentals and exceptional long-term growth potential. In this environment, it's important to remain selective, consider company-specific risks, and evaluate appropriate entry points and long-term portfolio allocations.
On October 19, 2026, PaySign Inc (PAYS) shares rose 3.6% to $15.34, continuing a notable upward trend with a 52-week range of $3.08 to $15.80. The stock has sho